When was Spark Biomedical founded?

Spark Biomedical was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is Spark Biomedical located?

Spark Biomedical is headquartered in Houston, United States.

Who is the current CEO of Spark Biomedical?

Daniel Powell of Spark Biomedical.

How many employees does Spark Biomedical have?

As of Apr 30, 2026, the latest employee count at Spark Biomedical is 27.

Is Spark Biomedical a funded company?

Spark Biomedical is a funded company, having raised a total of $31.2M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 30, 2019.

When was the latest funding round of Spark Biomedical?

Spark Biomedical's latest funding was a $***** Grant (prize money) round on Aug 19, 2025, with participation from 0 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $3.3B in funding in 2026 to date.

Where does Spark Biomedical rank among its competitors?

Spark Biomedical ranks 18th amongst 346 active competitors, of which 115 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Spark Biomedical, which secured an undisclosed amount in Aug, 2025.

Who are the top competitors of Spark Biomedical?

Spark Biomedical's top competitors include Ekso Bionics, Ceribell and Empatica. Among them, Spark Biomedical secured the most recent funding round in August, 2025.

Spark Biomedical - 2026 Company Profile, Team, Funding & Competitors

Spark Biomedical is a series A company based in Houston (United States), founded in 2018. It operates as a Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment. Spark Biomedical has raised $31.2M in funding from Wave Ventures. The company has 346 active competitors, including 115 funded and 23 that have exited. Its top competitors include companies like Ekso Bionics, Ceribell and Empatica.

Company Details

Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment. The company provides non-invasive bioelectric medicine designed to meet critical needs. Their current FDA-cleared neurostimulation solution is for opioid withdrawal. The technology is also evolving into neurological health, hemostasis, and pediatrics.

Key Metrics

Founded Year

2018

Location

Houston, United States

Stage

Series A

Total Funding

$31.2M in 7 rounds

Latest Funding Round

Grant (prize money), Aug 19, 2025, $*****

Investors

Wave Ventures & 6 more

Ranked

18^th among 346 active competitors

Employee Count

27 as on Apr 30, 2026

Similar Companies

Ceribell & 186 more

View Spark Biomedical's full profile

Spark Biomedical is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Spark Biomedical, Inc. CIN: 831903788 , United States, Active	Dec 31, 2017	-	9 (As on Dec 31, 2024)	-
Spark Biomedical Inc. CIN: 32068356933 , United States, Active	Sep 14, 2018	-	-	-

Spark Biomedical has raised a total funding of $31.2M over 7 rounds. Its first funding round was on Sep 30, 2019. Spark Biomedical has 7 institutional investors.

Here is the list of recent funding rounds of Spark Biomedical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 19, 2025	9122562	Grant (prize money)	4779790	6052165	4598517	8107636
Apr 30, 2025	2071033	Series A	8386085	1276464	1246295	Pathwaytocures
Jun 15, 2024	9030913	Grant (prize money)	7247087	6561175	3917283	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Spark Biomedical's funding rounds and investors

Spark Biomedical's employee count trend

Spark Biomedical has 27 employees as of Apr 26. Here is Spark Biomedical's employee count trend over the years:

Employee count trend for Spark Biomedical

Uncover Spark Biomedical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Spark Biomedical include Ekso Bionics, Ceribell and Empatica. Here is the list of Top 10 competitors of Spark Biomedical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ekso Bionics 2005, San Rafael (United States), Public	Developer of exoskeletons for rehabilitation and personal mobility assistance	$24.4M	Lockheed Martin, National Science Foundation ... & 14 others	70/100
2nd	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Ally Bridge Group & 11 others	69/100
3rd	Empatica 2011, Milano (Italy), Series B	Developer of a wrist band to monitor physiological signals	$30.9M	RA Capital Management, Sanofi Ventures & 5 others	67/100
4th	Wandercraft 2012, Paris (France), Series D	Provider of AI-powered exoskeleton solutions	$142M	Quadrant, Teampact Ventures & 21 others	66/100
5th	SuitX 2012, Berkeley (United States), Acquired	Exoskeleton solutions for industry, enhancing worker safety and productivity	$5.13M	Wistron, National Science Foundation & 2 others	65/100
6th	Myomo 2004, Boston (United States), Public	Provider of a robotic arm for mobility and rehabilitation	$17.2M	Mountain Group Partners, Children's Hospital of Philadelphia ... & 5 others	62/100
7th	Cumulus Neuro 2015, Belfast (United Kingdom), Series A	AI and cloud-based brain physiology analysis tool for clinical trials	$19.6M	Par Equity, Invest Northern Ireland & 29 others	61/100
8th	Freespira 2008, Danville (United States), Series D	Medical device & Mobile app to treat panic disorders	$48.9M	Lightspeed Venture Partners, Aphelion Capital ... & 4 others	60/100
9th	NeuroSigma 2008, Los Angeles (United States), Public	Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders	$2.92M	KT, HHS & 2 others	60/100
10th	Motif neurotech 2022, Houston (United States), Series A	Developer of minimally invasive bioelectronics for mental health disorders	$18.7M	Arboretum Ventures, re.Mind Capital & 9 others	60/100
18th	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	HHS, Wave Ventures & 5 others	57/100